DTRT Health Acquisition Corp. (DTRTU) Stock Analysis
DELISTED 2023
What happened to DTRT Health Acquisition Corp. (DTRTU) stock?
DTRT Health Acquisition Corp. (DTRTU) no longer trades on public markets. It was delisted in January 2023. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
DTRT Health Acquisition Corp. (DTRTU) trades at $10.30. DTRT Health Acquisition Corp. is a special purpose acquisition company (SPAC) focused on merging with a private healthcare business. Sector: Financial services.
Last analyzed: Mar 18, 2026Analyst Coverage for DTRTU: DTRTU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates DTRTU against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
DTRT Health Acquisition Corp. (DTRTU) Financial Services Profile
DTRT Health Acquisition Corp., a special purpose acquisition company (SPAC), is actively seeking a merger, asset acquisition, or similar business combination within the healthcare sector, aiming to bring a private entity to the public market; incorporated in 2021, it currently has no significant operations.
What Is the Investment Thesis for DTRTU?
DTRT Health Acquisition Corp. presents a speculative investment opportunity tied to its ability to identify and successfully merge with a high-growth healthcare company. The value proposition hinges on the management team's expertise in deal-making and the potential upside of the target company. A successful merger could lead to significant returns for shareholders, while failure to find a suitable target within the specified timeframe would likely result in liquidation and a return of capital. The company's P/E ratio is currently 29.10, reflecting market expectations of a successful acquisition. Key catalysts include identifying a target company and completing the merger. The primary risk is the inability to find a suitable target, leading to the return of capital to investors.
Based on FMP financials and quantitative analysis
DTRTU Key Highlights
Incorporated in 2021, DTRT Health Acquisition Corp. is a relatively new entity in the SPAC market.
- The company's sole purpose is to identify and merge with a private healthcare company.
- DTRT Health Acquisition Corp. has no operating history or revenue, as it is a blank check company.
- The company is based in Oak Brook, Illinois, indicating its operational base.
- The P/E ratio is 29.10, reflecting market expectations of a successful acquisition.
Who Are DTRTU's Competitors?
DTRTU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AGGI Allied Energy, Inc. | $2.25 | +32.24% | $45.4B | 61 |
| GSHN Gushen, Inc. | $22.70 | +2.71% | $9.32B | 61 |
| IVAN Ivanhoe Capital Acquisition Corp. | $7.68 | -2.17% | $2.69B | 64 |
| APXTW Apex Treasury Corporation | $0.35 | -5.41% | $1.89B | 66 |
| APXT Apex Technology Acquisition Corp. | $10.12 | -0.05% | $1.89B | 64 |
| APXTU Apex Treasury Corporation | $10.26 | +0.39% | $1.89B | 64 |
| WCHS Winchester Holding Group | $5.01 | +0.00% | $532M | 63 |
| MESH Meshflow Acquisition Corp. | $10.04 | -0.05% | $433M | 64 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are DTRTU's Key Strengths?
Access to capital through IPO.
- Experienced management team.
- Focus on the high-growth healthcare sector.
What Are DTRTU's Weaknesses?
No operating history.
- Dependence on finding a suitable target.
- Limited timeframe to complete a deal.
What Could Drive DTRTU Stock Higher?
Identification of a potential merger target in the healthcare sector.
- Announcement of a definitive merger agreement with a target company.
- Completion of the merger or acquisition transaction.
What Are the Key Risks for DTRTU?
Negative return on equity (-78.7%) — the business is not currently generating profit on shareholder capital.
- Inability to find a suitable target company within the specified timeframe.
- Failure to obtain shareholder approval for the merger.
- Changes in market conditions that could negatively impact the target company's value.
- Regulatory risks associated with the healthcare industry.
- Competition from other SPACs seeking acquisition targets.
What Are the Growth Opportunities for DTRTU?
- Successful Acquisition: DTRT Health Acquisition Corp.'s primary growth opportunity lies in identifying and acquiring a high-growth healthcare company. The size of the healthcare market is substantial, with significant potential for innovation and expansion. A successful acquisition could lead to significant revenue growth and market share gains for the combined entity. The timeline for this growth opportunity is dependent on the company's ability to find and close a deal, which could take several months to a year.
- Operational Improvements: Following a successful acquisition, DTRT Health Acquisition Corp. can focus on improving the operational efficiency and profitability of the target company. This could involve streamlining processes, reducing costs, and implementing new technologies. The potential for operational improvements is significant, as many private companies lack the resources and expertise to optimize their operations. The timeline for this growth opportunity is ongoing, as the company continuously seeks ways to improve its performance.
- Market Expansion: Once the target company is integrated, DTRT Health Acquisition Corp. can explore opportunities to expand its market reach. This could involve entering new geographic markets, targeting new customer segments, or launching new products and services. The potential for market expansion is substantial, particularly in the healthcare industry, which is characterized by rapid growth and innovation. The timeline for this growth opportunity is medium to long term, as it requires careful planning and execution.
- Strategic Partnerships: DTRT Health Acquisition Corp. can also pursue strategic partnerships with other companies in the healthcare industry. This could involve collaborating on research and development, sharing resources, or co-marketing products and services. Strategic partnerships can help the company to expand its capabilities, access new markets, and accelerate its growth. The timeline for this growth opportunity is ongoing, as the company continuously seeks opportunities to collaborate with other organizations.
- Technological Innovation: Investing in technological innovation is crucial for DTRT Health Acquisition Corp. to maintain a competitive edge in the rapidly evolving healthcare industry. This could involve developing new diagnostic tools, treatment methods, or healthcare delivery models. The potential for technological innovation is vast, as the healthcare industry is constantly seeking new and better ways to improve patient outcomes. The timeline for this growth opportunity is long term, as it requires significant investment in research and development.
What Are DTRTU's Competitive Advantages?
- DTRT Health Acquisition Corp.'s moat depends on its management team's expertise.
- The company's ability to identify and acquire a high-growth healthcare company is key.
- Access to capital through the IPO provides a competitive advantage.
What Does DTRTU Do?
DTRT Health Acquisition Corp. was founded in 2021 with the intent of identifying and merging with a promising private company within the healthcare industry. As a special purpose acquisition company, or SPAC, DTRT Health Acquisition Corp. does not have any operating history of its own. Instead, its sole purpose is to raise capital through an initial public offering (IPO) and then use that capital to acquire or merge with an existing business. The company is based in Oak Brook, Illinois. The company's strategy revolves around finding a target company that can benefit from the public market listing and the expertise of DTRT Health Acquisition Corp.'s management team. Once a target is identified, DTRT Health Acquisition Corp. will negotiate the terms of the merger or acquisition, conduct due diligence, and seek shareholder approval. If the transaction is successful, the target company will become a publicly traded entity, and DTRT Health Acquisition Corp. will cease to exist as a separate entity. As of 2026, DTRT Health Acquisition Corp. is still in the process of searching for a suitable target company.
What Products and Services Does DTRTU Offer?
- DTRT Health Acquisition Corp. is a special purpose acquisition company (SPAC).
- It aims to merge with a private healthcare company.
- The company raises capital through an initial public offering (IPO).
- It seeks a target company in the healthcare sector.
- DTRT Health Acquisition Corp. conducts due diligence on potential targets.
- It negotiates the terms of a merger or acquisition agreement.
- The company seeks shareholder approval for the transaction.
How Does DTRTU Make Money?
- DTRT Health Acquisition Corp. raises capital through an IPO.
- It uses the capital to acquire or merge with a private healthcare company.
- The target company becomes publicly traded through the merger.
What Industry Does DTRTU Operate In?
DTRT Health Acquisition Corp. operates within the special purpose acquisition company (SPAC) sector, a segment of the financial services industry characterized by companies formed to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing operating company. The SPAC market has seen significant growth in recent years, driven by the desire of private companies to access public markets more quickly and with less regulatory scrutiny than traditional IPOs. The competitive landscape includes numerous other SPACs, each seeking attractive acquisition targets. Success depends on the management team's ability to identify and execute a value-creating transaction.
Who Are DTRTU's Key Customers?
- DTRT Health Acquisition Corp.'s customers are its shareholders.
- The company seeks to deliver value to shareholders through a successful acquisition.
- The target company's customers become customers of the combined entity.
Company Profile
DTRT Health Acquisition Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Oak Brook, US. The company is led by CEO Mark S. Heaney. DTRTU has traded publicly since 2021.
Key Financial Metrics
Return on equity for DTRT Health Acquisition Corp. stands at -78.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.3%, showing how much profit it generates from its asset base. DTRTU trades at a trailing price-to-earnings ratio of 23.21, above the Financial Services sector average of ~18x. A current ratio of 3.88 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.3%, the inverse of the P/E and a quick read on earnings relative to price.
DTRTU Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating a belief in long-term value.
- Community sentiment has shifted positively, with discussions highlighting the potential for growth in the health sector.
- Analysts are noting strategic partnerships that could enhance DTRT's market position and drive revenue opportunities.
- The overall health acquisition space is gaining traction, attracting investor interest and increasing visibility for companies like DTRT.
Bear Case
- Concerns about regulatory challenges in the health acquisition sector could hinder operational progress and investor confidence.
- Recent community discussions reflect skepticism regarding the company's ability to execute on its growth strategy effectively.
- Market perception remains cautious due to the volatile nature of SPACs, with investors wary of past underperformers.
- Insider selling activity in the past has raised flags among investors, leading to doubts about the company's leadership commitment.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
DTRTU Latest News
No recent news available for DTRTU.
Classification
Industry Shell CompaniesLeadership: Mark S. Heaney
CEO
Mark S. Heaney serves as the CEO of DTRT Health Acquisition Corp. His background includes extensive experience in the financial services sector, with a focus on investment banking and private equity. He has held leadership positions at various firms, where he was responsible for sourcing, evaluating, and executing investment opportunities. Heaney's expertise spans across multiple industries, including healthcare, technology, and consumer products. His educational background includes an MBA from a top-tier business school and a bachelor's degree in finance.
Track Record: Under Mark S. Heaney's leadership, DTRT Health Acquisition Corp. has been actively searching for a suitable target company in the healthcare sector. While the company has not yet completed a merger or acquisition, Heaney has overseen the evaluation of numerous potential targets and has been instrumental in developing the company's investment strategy. His experience in deal-making and his network of contacts in the healthcare industry are valuable assets for DTRT Health Acquisition Corp.
What Investors Ask About DTRT Health Acquisition Corp. (DTRTU) — Financial Services
What happened to DTRT Health Acquisition Corp. (DTRTU) stock?
DTRT Health Acquisition Corp. (DTRTU) no longer trades on public markets. It was delisted in January 2023. The figures below are historical and are not a current quote.
Can I still buy DTRTU shares?
No. DTRTU stopped trading on public markets in January 2023, so the shares are not available through a broker. Anything you see quoted for DTRTU elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before DTRTU stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to DTRT Health Acquisition Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does DTRT Health Acquisition Corp. do?
DTRT Health Acquisition Corp. is a special purpose acquisition company (SPAC) created to identify and merge with a private company in the healthcare sector. As a blank check company, it has no operating history and exists solely to raise capital through an IPO and subsequently acquire an existing business.
What do analysts say about DTRTU stock?
As of March 18, 2026, there is limited analyst coverage specifically on DTRT Health Acquisition Corp. (DTRTU) due to its nature as a SPAC still seeking a target. The stock's performance is largely tied to speculation about potential merger targets and the perceived quality of the management team.
What are the main risks for DTRTU?
The primary risk for DTRT Health Acquisition Corp. is the inability to identify and merge with a suitable target company within the allotted timeframe, which typically results in the liquidation of the SPAC and the return of capital to investors.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- AI analysis is pending and may provide further insights.